These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24455664)

  • 21. The Importance of an In-depth Study of Immunoglobulin Gene Rearrangements When Ascertaining the Clonal Relationship between Concomitant Chronic Lymphocytic Leukemia and Multiple Myeloma.
    Trudel S; Ghamlouch H; Dremaux J; Delette C; Harrivel V; Marolleau JP; Gubler B
    Front Immunol; 2016; 7():625. PubMed ID: 28082975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease.
    van Driel M; Günthert U; Stauder R; Joling P; Lokhorst HM; Bloem AC
    Leukemia; 1998 Nov; 12(11):1821-8. PubMed ID: 9823960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current and future approaches to therapy for multiple myeloma].
    Nara N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):9-15. PubMed ID: 7826084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research Advance on Teatment of Second Primary Malignancy in Patients with Multiple Myeloma].
    Ma J; Wang YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1796-9. PubMed ID: 26708913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non Secretory Multiple Myeloma With Extensive Extramedullary Plasmacytoma: A Diagnostic Dilemma.
    Low SF; Mohd Tap NH; Kew TY; Ngiu CS; Sridharan R
    Iran J Radiol; 2015 Jul; 12(3):e11760. PubMed ID: 26528383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined renal proximal tubulopathy and crystal storing histiocytosis in a patient with κ light chain multiple myeloma.
    Ungari M; Ghiringhelli P; Marchi G; Fisogni S; Lavazza A; Molteni A; Malberti F; Bertoni R; Trombatore M; Ferrero G; Gusolfino MD; Varotti E; Tanzi G; Manotti L
    Pathologica; 2021 Aug; 113(4):285-293. PubMed ID: 34463673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Novel Immunotherapies for Multiple Myeloma.
    Al-Hujaily EM; Oldham RA; Hari P; Medin JA
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Multiple Myeloma Cancer Stem Cells with Natural Products - Lessons from Other Hematological Malignancies.
    Issa ME; Cretton S; Cuendet M
    Planta Med; 2017 Jun; 83(9):752-760. PubMed ID: 28472843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
    Lopes R; Caetano J; Ferreira B; Barahona F; Carneiro EA; João C
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
    Kim D; Park CY; Medeiros BC; Weissman IL
    Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory Features of Newly Diagnosed Multiple Myeloma Patients.
    Hussain A; Almenfi HF; Almehdewi AM; Hamza MS; Bhat MS; Vijayashankar NP
    Cureus; 2019 May; 11(5):e4716. PubMed ID: 31355076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to Diagnose, Treat, and Monitor Treatment Response in Patients with Multiple Myeloma.
    Rajabto W; Priantono D
    Acta Med Indones; 2022 Jul; 54(3):487-490. PubMed ID: 36156469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biclonal myeloma in renal failure.
    Nikolova-Vlahova MK; Kamburova M; Hristova J; Vasileiou D; Bogov B; Krasteva R; Hadjiev E; Tsvetkova G; Vasileva C; Houbanov N
    Cent Eur J Immunol; 2020; 45(1):122-124. PubMed ID: 32425690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal Models of Multiple Myeloma Bone Disease.
    Mehdi SH; Nafees S; Mehdi SJ; Morris CA; Mashouri L; Yoon D
    Front Genet; 2021; 12():640954. PubMed ID: 34163520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
    Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
    Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
    Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
    Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma.
    Welters C; Lammoglia Cobo MF; Stein CA; Hsu MT; Ben Hamza A; Penter L; Chen X; Buccitelli C; Popp O; Mertins P; Dietze K; Bullinger L; Moosmann A; Blanc E; Beule D; Gerbitz A; Strobel J; Hackstein H; Rahn HP; Dornmair K; Blankenstein T; Hansmann L
    Cancer Immunol Res; 2022 Nov; 10(11):1407-1419. PubMed ID: 36122410
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.